about
NMDA receptor antagonism with novel indolyl, 2-(1,1-Dimethyl-1,3-dihydro-benzo[e]indol-2-ylidene)-malonaldehyde, reduces seizures duration in a rat model of epilepsy.Preconditioning as a potential strategy for the prevention of Parkinson's disease.A Molecular Approach to Epilepsy Management: from Current Therapeutic Methods to Preconditioning Efforts.Glycogen synthase kinase-3 beta (GSK-3β) signaling: Implications for Parkinson's disease.Thyroid hormones: Possible roles in epilepsy pathology.The malleable brain: plasticity of neural circuits and behavior - a review from students to students.Mitochondrial Dysfunction and Biogenesis in Neurodegenerative diseases: Pathogenesis and Treatment.Brain Lipopolysaccharide Preconditioning-Induced Gene Reprogramming Mediates a Tolerance State in Electroconvulsive Shock Model of Epilepsy.Polycaprolactone Triol-Citrate Scaffolds Enriched with Human Platelet Releasates Promote Chondrogenic Phenotype and Cartilage Extracellular Matrix Formation
P50
Q36327838-95E8B9A3-531B-4D91-AE13-664611E1307CQ38201685-79B011F6-A348-41DB-8F1E-A0AAEE1A8B89Q38246632-3E1547D6-8C09-43CB-9BCE-BAFE94823136Q38398631-FD4FD127-3ECE-4ABC-8710-17FB4EF7A968Q38585256-300122E3-6050-4BE5-BAAB-B79D5E3863CEQ38668955-74D5A515-BF44-40A0-ACFC-2A717B0FFD73Q39016389-DF8CE010-31EF-4D39-8069-DCF65BFF09D8Q54967347-8D8B6241-7A4E-4E54-9914-D40AFA5884FCQ90857036-B5C95425-69FF-4B38-9457-659369B484D1
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Mojtaba Golpich
@en
Mojtaba Golpich
@nl
type
label
Mojtaba Golpich
@en
Mojtaba Golpich
@nl
prefLabel
Mojtaba Golpich
@en
Mojtaba Golpich
@nl
P31
P496
0000-0002-7042-1201